Clinical Trials Logo

Blepharoptosis clinical trials

View clinical trials related to Blepharoptosis.

Filter by:

NCT ID: NCT04235803 Not yet recruiting - Blepharoptosis Clinical Trials

Telemedicine Follow-up for Routine, Low-Risk Oculoplastic Surgery

Start date: July 1, 2021
Phase: N/A
Study type: Interventional

The investigators propose utilizing a simple telemedical protocol to allow patients to substitute the first post-operative visit with a remote survey that includes essential post-operative history, vision measurement, and photographs, all of which can be provided using a personal computer, tablet, or smart phone. The investigators have selected for this purpose a subset of oculoplastic procedures involving the eyelid and lacrimal system that have well-reported low rates of serious complications, since high-risk procedures will likely always require close, in-person care. The investigators hypothesize that telemedicine follow-up for the first post-operative week after low-risk oculoplastic surgery will decrease the time burden on patients without compromising their satisfaction or increase the risk of late post-operative complications.

NCT ID: NCT04214379 Completed - Blepharoptosis Clinical Trials

Management of Severe Congenital Blepharoptosis

Start date: February 1, 2017
Phase: N/A
Study type: Interventional

Frontalis sling surgery was carried out using Ptose-up under general anaesthesia for patients with severe congenital ptosis.

NCT ID: NCT03916107 Enrolling by invitation - Ptosis, Eyelid Clinical Trials

Comparison of Different Surgical Treatments for Severe Ptosis Correction

Start date: January 1, 2018
Phase: N/A
Study type: Interventional

Main research purposes of this research is to compare the therapeutic effect and safety of the superior levator muscle shortening combined with the tarsus resection and the traditional frontal muscle flap in the correction of severe ptosis. Aside of above we also tend to explore the dose-effect relationship between the amount of levator muscle shortened/ tarsus resection and postoperative ptosis correction amount.So as to develop a more critical and specific guidelines for clinical treatment of ptosis. So during the research we will recruiting patients with severe ptosis and randomly divide them into levator muscle and tarsus group and frontal muscle flap group, and follow up those patient 6 months post operation so as to evaluate the amount of correction and the side-symptoms.

NCT ID: NCT03818204 Completed - Stroke Clinical Trials

Clinical Trial to Improve the Magnetic Levator Prosthesis

Start date: February 7, 2019
Phase: N/A
Study type: Interventional

Blepharoptosis (incomplete opening of the eyelids) occurs because of a disruption in the normal agonist-antagonist neuro-muscular complex balance. An external device could restore eyelid movement. A newer class of permanent magnets made of alloys of neodymium (Nd), iron (Fe) and boron (B) might provide the technology needed to develop a feasible external magnetic device that could restore eyelid movement.

NCT ID: NCT03812016 Recruiting - Blepharoptosis Clinical Trials

A Real-time Magnetic Device for Temporary Management of Blepharoptosis

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

To develop a real-time magnetic device prototype for temporary management of blepharoptosis and evaluate its efficacy and safety, including the gain of palpebral fissure height, visual axis obstruction, blurred vision, foreign body sensation over the cornea, burning or hot sensation over facial skin, and erythema or pruritus over the eyelid, by performing a human trial on patients with unilateral blepharoptosis.

NCT ID: NCT03782701 Completed - Eyelid Droop Clinical Trials

The Effect of Lumify™ Eyedrops on Eyelid Position

Start date: June 18, 2019
Phase: Phase 4
Study type: Interventional

The purpose of the research is to see if Lumify™ has an effect on eyelid position.

NCT ID: NCT03565887 Completed - Blepharoptosis Clinical Trials

Study of Safety and Efficacy of RVL-1201 in the Treatment of Blepharoptosis

Start date: June 28, 2018
Phase: Phase 3
Study type: Interventional

Phase 3 study to evaluate the safety and efficacy of treatment with RVL-1201 compared to placebo for treatment of blepharoptosis. Eligible subjects will be randomized to one of 2 treatment arms.

NCT ID: NCT03536949 Completed - Blepharoptosis Clinical Trials

Study of Safety of RVL-1201 in Treatment of Blepharoptosis

Start date: June 20, 2018
Phase: Phase 3
Study type: Interventional

Phase 3 study to evaluate the extended safety of RVL-1201 compared to placebo for treatment of blepharoptosis. Eligible subjects will be randomized to one of 2 treatment arms.

NCT ID: NCT03396627 Not yet recruiting - Clinical trials for Eyelid Movement Disorders

Müller's Muscle as a New Proprioceptive Organ

Start date: January 15, 2018
Phase: N/A
Study type: Observational

Objectives: Upper eyelid retraction was believed to be maintained solely by voluntary contraction of the levator palpebrae superioris (LPS) and frontalis muscles, together with involuntary contraction of the sympathetically innervated Müller's muscle (MM). However, several studies have suggested that the LPS also undergoes involuntary contractions, and that a visual stimulus may not be the only trigger for frontalis muscle contractions. Recent studies hypothesized that the MM contains proprioceptive neuronal structures, which elicit involuntary LPS muscle contraction by the mesencephalic trigeminal nucleus via a continuous stretch reflex. We aim to identify proprioceptive structures in MM by means of histological examinations. Methodology: Prospective study. Collaboration of oculoplastics, ophthalmologists and a neuroanatomy specialist in Sheba Medical Center. 50 fresh MM specimens from patients undergoing Müllerectomies will undergo histologic examinations, including immunohistochemical staining and light and electron microscopy. Significance: Identification of proprioceptive structures in MM will be the first evidence-based proof of a proprioceptive mechanism in the eyelid. This might have a significant impact on future surgical management of eyelid procedures. Comprehensive understanding of the mechanisms underlying eyelid function is especially important in the management of children with ptosis who may have coexisting amblyopia.

NCT ID: NCT03392272 Not yet recruiting - Clinical trials for Surgical Procedure, Unspecified

Modified Müller's Muscle-conjunctival Resection Internal Ptosis Repair Using Fibrin Glue

Start date: February 1, 2018
Phase: N/A
Study type: Interventional

Fibrin glue is widely used in ophthalmology for homeostasis and tissue recovery. It is commonly used in ocular surface surgeries such as pterygium removal and conjunctival lesions excisions. In Müller's muscle-conjunctival resection (MMCR), sutures are used to reconnect the conjunctiva and Muller muscle, which causes discomfort and pain for the patient. The investigators' goal is to explore using fibrin glue instead of sutures in MMCR surgeries to shorten the procedure's length and alleviate patients discomfort and pain. This is especially important in the management of children suffering ptosis, where sedation and even general anaesthesia is required for sutured removal as a secondary procedure.